Ajanta Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE031B01049
  • NSEID: AJANTPHARM
  • BSEID: 532331
INR
3,213.80
25.05 (0.79%)
BSENSE

Jun 23, 01:42 PM

BSE+NSE Vol: 1.35 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
25.07
25.07
25.27
25.27
17.17
17.39
Share Warrants & Outstandings
Total Reserve
4,498.80
3,760.04
3,536.44
3,362.38
3,246.87
2,977.70
Shareholder's Funds
4,527.09
3,790.29
3,567.36
3,387.99
3,264.34
2,995.63
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
0.00
0.00
0.00
1.25
1.64
1.60
Secured Loans
0.00
0.00
0.00
1.25
1.64
1.60
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
-70.65
-75.91
-25.95
0.95
46.32
42.07
Other Long Term Liabilities
42.91
37.77
27.23
28.63
21.02
22.76
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
51.15
80.27
39.54
24.15
19.32
17.93
Total Non-Current Liabilities
23.41
42.13
40.82
54.98
88.30
84.36
Current Liabilities
Trade Payables
544.30
454.20
463.20
422.77
327.17
373.86
Other Current Liabilities
629.07
515.96
413.31
702.31
309.41
263.06
Short Term Borrowings
211.99
2.59
1.49
0.18
0.00
0.00
Short Term Provisions
30.39
23.35
17.76
14.02
10.81
11.71
Total Current Liabilities
1,415.75
996.10
895.76
1,139.28
647.39
648.63
Total Liabilities
5,966.25
4,828.52
4,503.94
4,582.25
4,000.03
3,728.62
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
2,914.76
2,677.45
2,279.29
2,183.12
2,102.04
2,012.54
Less: Accumulated Depreciation
1,146.83
1,006.06
880.50
767.54
668.71
572.55
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
1,767.93
1,671.39
1,398.79
1,415.58
1,433.33
1,439.99
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
258.05
176.27
256.45
209.47
152.86
108.19
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
28.50
25.24
18.58
25.10
33.51
8.90
Long Term Loans & Advances
75.75
18.25
18.09
15.88
43.64
45.49
Other Non Current Assets
1.57
3.71
0.71
1.36
1.98
6.24
Total Non-Current Assets
2,230.82
1,985.49
1,773.02
1,748.25
1,735.57
1,701.03
Current Assets Loans & Advances
Current Investments
559.85
438.71
330.05
510.27
121.86
175.67
Inventories
938.54
903.85
828.36
815.63
791.07
766.47
Sundry Debtors
1,853.88
1,182.74
1,246.84
1,056.90
1,019.81
738.43
Cash and Bank
104.77
176.24
130.77
330.90
211.79
209.61
Other Current Assets
169.47
76.82
110.37
68.70
78.15
102.39
Short Term Loans and Advances
108.92
64.67
84.53
51.60
41.78
35.02
Total Current Assets
3,735.43
2,843.03
2,730.92
2,834.00
2,264.46
2,027.59
Net Current Assets (Including Current Investments)
2,319.68
1,846.93
1,835.16
1,694.72
1,617.07
1,378.96
Total Current Assets Excluding Current Investments
3,175.58
2,404.32
2,400.87
2,323.73
2,142.60
1,851.92
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
5,966.25
4,828.52
4,503.94
4,582.25
4,000.03
3,728.62
Contingent Liabilities
8.12
8.12
4.94
4.55
7.28
82.90
Total Debt
211.99
2.59
1.49
1.43
1.64
1.60
Book Value per share (adjusted)
361.16
302.38
282.34
268.14
253.495023300155
229.681531210208
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 8,084.94% vs 73.83% in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 13.61% vs 38.71% in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is 9.65% vs 11.62% in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 12.92% vs 35.84% in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 31.39% vs 4.11% in Mar 2025

Compare Balance Sheet Results of Ajanta Pharma
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
25.07
169.41
-144.34
-85.20%
Share Warrants & Outstandings
Total Reserve
4,498.80
2,113.72
2,385.08
112.84%
Shareholder's Funds
4,527.09
2,267.42
2,259.67
99.66%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
-70.65
-133.85
63.20
47.22%
Other Long Term Liabilities
42.91
17.27
25.64
148.47%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
51.15
260.07
-208.92
-80.33%
Total Non-Current Liabilities
23.41
143.50
-120.09
-83.69%
Current Liabilities
Trade Payables
544.30
570.22
-25.92
-4.55%
Other Current Liabilities
629.07
789.73
-160.66
-20.34%
Short Term Borrowings
211.99
0.00
211.99
0.00%
Short Term Provisions
30.39
419.15
-388.76
-92.75%
Total Current Liabilities
1,415.75
1,779.10
-363.35
-20.42%
Total Liabilities
5,966.25
4,190.02
1,776.23
42.39%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
2,914.76
645.02
2,269.74
351.89%
Less: Accumulated Depreciation
1,146.83
396.70
750.13
189.09%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
1,767.93
248.32
1,519.61
611.96%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
258.05
32.93
225.12
683.63%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
28.50
1.52
26.98
1,775.00%
Long Term Loans & Advances
75.75
222.23
-146.48
-65.91%
Other Non Current Assets
1.57
47.07
-45.50
-96.66%
Total Non-Current Assets
2,230.82
583.82
1,647.00
282.11%
Current Assets Loans & Advances
Current Investments
559.85
1,390.96
-831.11
-59.75%
Inventories
938.54
457.55
480.99
105.12%
Sundry Debtors
1,853.88
273.11
1,580.77
578.80%
Cash and Bank
104.77
1,391.02
-1,286.25
-92.47%
Other Current Assets
169.47
36.45
133.02
364.94%
Short Term Loans and Advances
108.92
57.10
51.82
90.75%
Total Current Assets
3,735.43
3,606.20
129.23
3.58%
Net Current Assets (Including Current Investments)
2,319.68
1,827.09
492.59
26.96%
Total Current Assets Excluding Current Investments
3,175.58
2,215.24
960.34
43.35%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
5,966.25
4,190.02
1,776.23
42.39%
Contingent Liabilities
8.12
515.18
-507.06
-98.42%
Total Debt
211.99
0.00
211.99
0.00%
Book Value per share (adjusted)
361.16
133.85
227.31
169.82%
Annual - Borrowings
Borrowings 211.99 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 8,084.94% vs 73.83% in Mar 2025

Annual - Other Long Term Liabilities
Other Long Term Liabilities 42.91 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 13.61% vs 38.71% in Mar 2025

Annual - Fixed Assets
Fixed Assets 2,025.98 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 9.65% vs 11.62% in Mar 2025

Annual - Investments
Investments 28.50 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.92% vs 35.84% in Mar 2025

Annual - Current Assets
Current Assets 3,735.43 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 31.39% vs 4.11% in Mar 2025